Table 2.
Parameters |
ROP |
No ROP |
Univariate analysis |
|
---|---|---|---|---|
n newborns (%) | OR | p-value | ||
GA ≤ 24 weeks |
71 (75%) |
24 (25%) |
2.01 |
0.008 |
BW ≤ 750 g |
168 (68%) |
78 (32%) |
1.73 |
0.007 |
Male gender |
111 (45%) |
71 (46%) |
0.96 |
0.848 |
Inborn |
217 (86%) |
141 (90%) |
0.68 |
0.238 |
APGAR score 5th minute ≤ 7 |
125 (56%) |
72 (49%) |
1.31 |
0.205 |
PROM |
78 (34%) |
44 (29%) |
1.22 |
0.380 |
Chorioamnionitis |
60 (31%) |
33 (23%) |
1.47 |
0.130 |
Antenatal steroids |
198 (81%) |
133 (88%) |
0.59 |
0.085 |
RDS |
234 (100%) |
150 (100%) |
Not applicable |
|
PDA |
167 (66%) |
84 (34%) |
1.96 |
0.002 |
IVH |
118 (71%) |
49 (29%) |
2.10 |
0.001 |
LPV |
44 (19%) |
55 (38%) |
1.22 |
0.543 |
Sepsis |
134 (70%) |
57 (30%) |
2.02 |
0.001 |
BPD |
142 (61%) |
66 (45%) |
1.94 |
0.002 |
Blood transfusions |
217 (90%) |
140 (90%) |
0.93 |
0.833 |
EPO therapy |
147 (70%) |
63 (30%) |
2.39 |
< 0.0001 |
Mechanical ventilation (>7 days) |
157 (71%) |
101 (67%) |
1.20 |
0.432 |
NPT ( > 7 days) | 185 (83%) | 118 (78%) | 1.37 | 0.234 |